Florida Development in Early Childhood: Adversity and Drug Exposure (FL-DECADE) Study

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2019
    2021
  • Known Financial Commitments (USD)

    $189,329
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    UNIVERSITY OF FLORIDA
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

PROJECT SUMMARYIn this administrative supplement application, we propose to expand the original aims of ourFlorida Development in Early Childhood: Adversity and Drug Exposure (FL-DECADE) Study(R34DA050299) to accomplish NIDA research objectives related to the 2019 Novel Coronavirus(2019-nCoV, also known as COVID-19). As part of Phase I of the Healthy Brain and ChildDevelopment (HBCD) Study, the proposed activities of this supplement will provide additionalinformation related to the feasibility of a long-term cohort study of pregnant women and children(HBCD Phase II). COVID-19 will assuredly impact families through the planned enrollment periodof Phase II, thus the knowledge gained from the activities proposed in this administrativesupplement are critical to the early success of the Phase II cohort. Through this administrativesupplement, we will gain a broad understanding of stress and anxiety faced by pregnant andparenting women in Florida, and how their daily lives and prenatal care has changed during thepandemic. We will assess the feasibility of using a very large clinical data research network toidentify pregnant women who are COVID-19 positive in the event it is decided to target thispopulation for recruitment in Phase II. Finally, we will also test the feasibility of using innovativeways to remotely collect data from the home, which will be valuable in developing a long-termcohort study.